Exelixis
EXEL
#2378
Rank
$6.09 B
Marketcap
$20.91
Share price
-1.51%
Change (1 day)
8.62%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yields for this company